AIDS and Behavior

, Volume 11, Issue 2, pp 185–194 | Cite as

Drug Use and Medication Adherence among HIV-1 Infected Individuals

  • Charles H. Hinkin
  • Terry R. Barclay
  • Steven A. Castellon
  • Andrew J. Levine
  • Ramani S. Durvasula
  • Sarah D. Marion
  • Hector F. Myers
  • Douglas Longshore
Original Paper

Abstract

This longitudinal study examined the impact of drug use and abuse on medication adherence among 150 HIV-infected individuals, 102 who tested urinalysis positive for recent illicit drug use. Medication adherence was tracked over a 6-month period using an electronic monitoring device (MEMS caps). Over the 6-month study drug-positive participants demonstrated significantly worse medication adherence than did drug-negative participants (63 vs. 79%, respectively). Logistic regression revealed that drug use was associated with over a fourfold greater risk of adherence failure. Stimulant users were at greatest risk for poor adherence. Based upon within-participants analyses comparing 3-day adherence rates when actively using versus not using drugs, this appears to be more a function of state rather than trait. These data suggest that it is the acute effects of intoxication, rather than stable features that may be characteristic of the drug-using populace, which leads to difficulties with medication adherence.

Keywords

HIV infection AIDS Medication adherence Drug use Methamphetamine Cocaine 

Notes

Acknowledgments

This study was supported by a grant from the National Institute on Drug Abuse (RO1 DA13799) to CHH. The authors would like to thank Marta Robinet, Adam Perkins, and Oscar Ureño for their research assistance.

References

  1. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Change, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(18), 1417–1423.PubMedCrossRefGoogle Scholar
  2. Arnsten, J., Demas, P., Grant, R., Gourevitch, M., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17(5), 377–381.PubMedGoogle Scholar
  3. Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N., & Arnsten, J. H. (2004). Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19(11), 1111–1117.PubMedCrossRefGoogle Scholar
  4. Bangsberg, D. R., Bronstone, A., & Hofmann, R. (2002). A computer based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care, 14(1), 3–15.PubMedCrossRefGoogle Scholar
  5. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14(4), 357–366.PubMedCrossRefGoogle Scholar
  6. Burke, L. E. (2001). Electronic measurement. In Burke L. E., & Ockene I. S. (Eds.), Compliance in healthcare and research. Armonk, NY: Futura Publishing Company.Google Scholar
  7. Burney, K. D., Krishnan, K., Ruffin, M. T., Zhang, D., & Brenner, D. E. (1996). Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Archives of Family Medicine, 5, 297–300.PubMedCrossRefGoogle Scholar
  8. Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., et al. (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.PsychiatryResearch: Neuroimaging, 114(2), 65–79.CrossRefGoogle Scholar
  9. Chesney, M., Morin, M., & Sherr, L. (2000). Adherence to HIV combination therapy. Social Science & Medicine, 50, 1599–1605.CrossRefGoogle Scholar
  10. Chermack, S. T., Roll, J., Reilly, M., Davis, L., Kilaru, U., & Grabowski, J. (2000). Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug & Alcohol Dependence, 59(1), 43–49.CrossRefGoogle Scholar
  11. Colfax, G., & Shoptaw, S. (2005). The methamphetamine epidemic: Implications for HIV prevention and treatment. Current HIV/AIDS Reports, 2(4), 194–199.PubMedCrossRefGoogle Scholar
  12. Crisp, B. R., Williams, M., Timpson, S., & Ross, M. W. (2004). Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS and Behavior, 8(2), 199–206.PubMedCrossRefGoogle Scholar
  13. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160(14), 2101–2107.PubMedCrossRefGoogle Scholar
  14. Ehrman, R. N., Robbins, S. J., & Cornish, J. W. (1997). Comparing self-reported cocaine use with repeated urine tests in outpatient cocaine abusers. Experimental and Clinical Psychopharmacology, 5(2), 150–156.PubMedCrossRefGoogle Scholar
  15. Fendrich, M., Johnson, T. P., Wislar, J. S., Hubbell, A., & Spiehler, V. (2004). The utility of drug testing in epidemiological research: Results from a general population survey. Addiction, 99, 197–208.PubMedCrossRefGoogle Scholar
  16. Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E., & Lawrence, J. B. (2004). The concordance of self-report with other measures of medication adherence: A summary of the literature. Medical Care, 42(7), 649–652.PubMedCrossRefGoogle Scholar
  17. Garcia de Olalla, P., Knobel, H., Carmona, A., Gnelar, A., Lopez-Colmes, J. L., & Cayla, J. A. (2002). Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome, 30, 105–110.CrossRefGoogle Scholar
  18. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patient on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndrome, 23, 386–395.Google Scholar
  19. Golin, C.E., Liu, H., Hays, H.D., Miller, L.G., Beck, C.K., Ickovics, J., et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756–765.PubMedCrossRefGoogle Scholar
  20. Gonzalez, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B.C., et al. (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug and Alcohol Dependence, 76(2), 181–190.PubMedCrossRefGoogle Scholar
  21. Halkitis, P.N., Kutnick, A.H., & Slater, S. (2005). The social realities of adherence to protease inhibitor regimens: Substance use, health care and psychological states. Journal of Health Psychology, 10(4), 545–558.PubMedCrossRefGoogle Scholar
  22. Hinkin, C. H., Castellon, S. A., Atkinson, J. H., & Goodkin, K. (2001). Neuropsychiatric aspects of HIV infection among older adults. Journal of Clinical Epidemiology, 54(Suppl 1), S44–52.PubMedCrossRefGoogle Scholar
  23. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., et al. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950.PubMedGoogle Scholar
  24. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(1), S19–S25.PubMedCrossRefGoogle Scholar
  25. Hogg, R. S., Heath, K. V., Yip, B., Craib, K. J., O’Shaughnessy, M. V., Schechter, M. T., et al. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. Journal of the American Medical Association, 279(6), 450–454.PubMedCrossRefGoogle Scholar
  26. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., et al. (2002). A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, 2175–2182.PubMedCrossRefGoogle Scholar
  27. Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16(2), 199–211.PubMedCrossRefGoogle Scholar
  28. Kalichman, S. C., Ramachandran, B., & Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14, 267–273.PubMedCrossRefGoogle Scholar
  29. Kilpatrick, B., Howlett, M., Sedgwick, P., & Ghodse, A. H. (2000). Drug use, self report and urinalysis. Drug and Alcohol Dependence, 58, 111–116.PubMedCrossRefGoogle Scholar
  30. Kimmerling, M., Wagner, G., & Ghosh-Dastidar, B. (2003). Factors associated with accurate self-reported adherence to HIV antiretrovirals. International Journal of STD & AIDS, 14, 281–284. .CrossRefGoogle Scholar
  31. Letendre, S. L., Cherner, M., Ellis, R. J., Marquie-Beck, J., Gragg, B., Marcotte, T., et al. (2005). The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: Biological correlates of disease. AIDS, 19(Suppl 3), S72–S78.PubMedCrossRefGoogle Scholar
  32. Levine, A., Hardy, D., Miller, E., Castellon, S., Longshore, D., & Hinkin, C. (2006). The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 28, 29–42.PubMedCrossRefGoogle Scholar
  33. Levine, A., Hinkin, C, Marion, S., Keuning, A., Castellon, S., Lam, M., et al. (In press, 2006). Adherence to antiretroviral medications in HIV: Differences in data collected via self-report and electronic monitoring. Health Psychology..Google Scholar
  34. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977.PubMedGoogle Scholar
  35. Lu, N. T., Taylor, B. G., & Riley, K. J. (2001). The validity of adult arrestee self-reports of crack cocaine use. American Journal of Drug & Alcohol Abuse, 27(3), 399–419.CrossRefGoogle Scholar
  36. Matthews, W.C., Mar-Tang, M., Ballard, C., Colwell, B., Abulhosn, K., Noonan, C., et al. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patient Care and STDs, 16(4), 157–172.CrossRefGoogle Scholar
  37. Mohammed, H., Kieltyka, L., Richardson-Alston, G., Magnus, M., Fawal, H., Vermund, S. H., et al. (2004). Adherence to HAART among HIV-infected persons in Rural Louisiana. AIDS Patient Care and STDs, 18(5), 289–296.PubMedCrossRefGoogle Scholar
  38. Murphy, E. L., Collier, A. C., Kalish, L. A., Assmann, S. F., Para, M. R., Flanigan, T. P., et al. (2001). Highly active antiretroviral therapy decreases mortality and morbidity in patient with advanced HIV disease. Annals of Internal Medicine, 135, 17–26.PubMedGoogle Scholar
  39. Nieuwkerk, P. Y., Sprangers, M. A., Burger, D. M., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort. Archives of Internal Medicine, 161, 1962–1968.PubMedCrossRefGoogle Scholar
  40. O’Brien, M. K., Petrie, K., & Raeburn, J. (1992). Adherence to medication regimens: Updating a complex medical issue. Medical Care Review, 49, 435–454.PubMedCrossRefGoogle Scholar
  41. Ory, M. G., & Mack, K. A. (1998). Middle-aged and older people with AIDS. Research on Aging, 20, 653–664.Google Scholar
  42. Palella, F. J. Jr., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine, 338(13), 853–860.PubMedCrossRefGoogle Scholar
  43. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30.PubMedGoogle Scholar
  44. Paterson, D., Potoski, B., & Capitano, B. (2002). Measurement of adherence to antiretroviral medications. JAIDS, 31, S103–S106.PubMedGoogle Scholar
  45. Rabkin, J. G., & Chesney, M. (1999). Treatment adherence to HIV medications: The Achilles heel of the new therapeutics. In Ostrow D., Kalichman S. (Eds.), Behavioral and mental health impacts of new HIV therapies. New York: Plenum Press.Google Scholar
  46. Reback, C. J., Larkins, S., & Shoptaw, S. (2003). Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care, 15(6), 775–785.PubMedCrossRefGoogle Scholar
  47. Rippeth, J. D., Heaton, R. K., Carey, C. L., Marcotte, T. D., Moore, D. J., Gonzalez, R., et al. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1–14.PubMedCrossRefGoogle Scholar
  48. Sharpe, T.T., Lee, L.M., Nakashima, A.K., Elam-Evans, L.D., & Fleming, P.L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29(2), 117–27.PubMedCrossRefGoogle Scholar
  49. Simoni, J. M., Frick, P. A., & Huang, B. (2006). A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychology, 25(1), 74–81.PubMedCrossRefGoogle Scholar
  50. Smith, M. Y., Rapkin, B. D., Morrison, A., & Kammerman, S. (1997). Zidovudine adherence in persons with AIDS: Relation of patient beliefs about medications to self-termination of therapy. Journal of General Internal Medicine, 12, 216–223.PubMedGoogle Scholar
  51. Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M., B. (1992). The Structured Clinical Interview for DSM-III--R (SCID): I. History, rationale, and description. Archives of General Psychiatry, 49(8), 624–629.PubMedGoogle Scholar
  52. Stein, M. D., Rich, J. D., Maksad, J., Chen, M. H., Hu, P., Sobota, M., et al. (2000). Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. American Journal of Drug and Alcohol Abuse, 26(2), 195–205.PubMedCrossRefGoogle Scholar
  53. Stephenson, B. J., Rowe, B. H., Haynes, R. B., Macharia, W. M., & Leon, G. (1993). Is this patient taking the treatment as prescribed? Journal of the American Medical Association, 269, 2779–2781.PubMedCrossRefGoogle Scholar
  54. Tassiopoulos, K. B., Bernstein, J., Heeren, T., Levenson, S., Hingson, R., & Bernstein, E. (2004). Hair testing and self report of cocaine use by heroin users. Addiction, 99(5), 590–597.PubMedCrossRefGoogle Scholar
  55. Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23(4), 363–370.PubMedCrossRefGoogle Scholar
  56. Volkow, N. D., Chang, L., Wang, G., Fowler, J. S., Leonido-Yee, M., Franceschi, D., et al. (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 158(3), 377–382.PubMedCrossRefGoogle Scholar
  57. Wainberg, M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977–1983.PubMedCrossRefGoogle Scholar
  58. Wohl, D., Stephenson, B., Golin, C., Kiziah, N., Rosen, D., Ngo, B., et al. (2003). Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clinical Infectious Diseases, 36, 1572–1576.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Charles H. Hinkin
    • 1
    • 2
  • Terry R. Barclay
    • 1
  • Steven A. Castellon
    • 1
    • 2
  • Andrew J. Levine
    • 1
  • Ramani S. Durvasula
    • 3
  • Sarah D. Marion
    • 4
  • Hector F. Myers
    • 5
    • 6
  • Douglas Longshore
    • 1
  1. 1.David Geffen School of MedicineUniversity of California at Los AngelesLos AngelesUSA
  2. 2.VA Greater Los Angeles Health Care SystemLos AngelesUSA
  3. 3.California State University at Los AngelesLos AngelesUSA
  4. 4.Point Loma UniversitySan DiegoUSA
  5. 5.University of California at Los AngelesLos AngelesUSA
  6. 6.Research Center on Ethnicity, Health & BehaviorCharles R. Drew University of Medicine Los AngelesUSA

Personalised recommendations